Expert Opinion on Biological Therapy (1471-2598; 1744-7682) is a MEDLINE-indexed, international journal publishing peer-reviewed research across all aspects of biological therapy.
Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease.
The journal welcomes:
Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicine
Drug evaluations reviewing the clinical data on a particular biological agent
Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice
Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;
Article Highlights – an executive summary of the author’s most critical points.
《Expert Opinion On Biological Therapy》是一本由TAYLOR & FRANCIS LTD出版商出版的專業醫學期刊,該刊創刊于2001年,刊期Bimonthly,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 3區,小類學科:生物工程與應用微生物 3區;醫學:研究與實驗 3區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋生物工程與應用微生物等領域,旨在及時、準確、全面地報道國內外生物工程與應用微生物工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為5.589,平均審稿速度一般,3-8周。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 3區 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應用微生物 MEDICINE, RESEARCH & EXPERIMENTAL 醫學:研究與實驗 | 3區 3區 | 否 | 是 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q1 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Q1 | 5.589 |
MEDICINE, RESEARCH & EXPERIMENTAL | Q2 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
5.589 | 75 | 9.98% | 44.09% | 未開放 | 一般,3-8周 |